Sarcoidosis in Northern Israel; clinical characteristics of 120 patients

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 19, Issue 3, 2002, Pages 220-226

  Yigla, Mordekai ^a   Badarna Abu Ria, Nahala ^a   Tov, Nareh ^a   Ravell Weiller, Daniel ^a   Rubin, Ami Hai E ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Incidence; Israel; Sarcoidosis

Indexed keywords

CORTICOSTEROID; CYTOTOXIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DEATH; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SARCOIDOSIS; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; INCIDENCE; ISRAEL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 0036792633     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Newman LS, Rose CS, Maier LA: Sarcoidosis. N Eng J Med 1997; 24: 1224-34.
2. DeRemce RM: Sarcoidosis - Concise review for primary-care physicians. Mayo Clinic Proc 1995; 70: 177-81.
3. Siltzbach LE, James DG, Neville E, et al: Course and prognosis of Sarcoidosis around the world. Am J Med 1974; 57: 847-52.
4. Statement on Sarcoidosis. The Joint Statement of the American Thoracic Society, The European Respiratory Society and The World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). Am J Respir Crit Care Med 1999; 160: 736-55.
5. Nagai S: Pulmonary Sarcoidosis: Pathogenesis and population differences. Internal Medicine 1995; 34: 833-8.
6. Izumi T: Symposium: population differences in clinical features and prognosis of sarcoidosis throughout the world. Sarcoidosis 1992; 9: s105-s118.
7. Kim DS: Sarcoidosis in Korea: report of the second nationwide survey. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18 (2): 176-80.
8. Larsen F, Pehrsson SK, Hammer N, et al: ECG-abnormalities in Japanese and Swedish patients with sarcoidosis. A comparison. Sarcoidosis Vasc Diffuse Lung Dis 2001: 18 (3): 284-8.
9. Martinetti M, Tinnelli C, Kolek V, et al: The Sarcoidosis Map. A joint survey of clinical and immuno-genetic findings in two European countries. Am J Respir Crit Care Med 1995;152:557-564.
10. Jonathan CW: South-Western Internal Medicine Conference. Sarcoidosis: Immunology and clinical management. Ant J Med Sci 1994; 307: 233-45.
11. Amital H, Shibi G, Rozenman E, Sheinfield E: Clinical and pathological discussions. Harefuah 1994; 527: 564-7.
12. ACCESS Research Group: Design of a case controlled etiologic study of sarcoidosis. (ACCESS). J Clin Epidemiol 1999; 52: 1173-86.
13. Bresnitz EA, Strom BL: Epidemiology of Sarcoidosis. Epidmiol Rev 1983; 5: 124-56.
14. Hillerdal G, Nou E, Osterman K, et al: Sarcoidosis. Epidemiology and Prognosis. A 15-year European Study. Am Rev Respir Med 1984; 130: 29-32.
15. Yamaguchi M, Hosoda Y, Sasaki R, et al: Epidemiological study on Sarcoidosis in Japan, Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis 1989; 6: 138-46.
16. Baugman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA: Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885-9.
17. Milman N, Selroos O: Pulmonary Sarcoidosis in the Nordic countries 1950-1982: epidemiological and clinical picture. Sarcoidosis 1990; 7: 50-7.
18. Pientinalho A, Hiraga Y, Hosoda Y, Lofroos AB, Yamayuchi SO: The frequency of Sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiologic study. Sarcoidosis 1995; 12: 61-7.
19. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT: The epidemiology of Sarcoidosis in Rochester, Minnesota: a population based study of incidence and survival. Am J Epidemiol 1986; 123: 840-5.
20. James DG: Sarcoidosis and other granulomatous disorders. Marcel Dekker, 1994, New-York.
21. Keller AZ: Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of Sarcoidosis. Am J Epidemiol 1971; 94: 222-30.
22. Hunninghake GW, Gilbert S, Pueringer R, et al: Outcome of the treatment for Sarcoidosis. Am J Respir Crit Care Med 1994; 149: 893-8.
23. Chappell AG, Cheung MY, Hutchings HA: Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17 (2): 167-73.
24. Pietinalho A, Ohmichi M, Lofroos AB, Hiraga Y, Selroos O: The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy proven sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17 (2): 158-66.
25. McGrath DS, Goli N, Foley PJ, Du Bois RM: Sarcoidosis: genes and microbes-soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001; 18 (2): 149-64.
26. Niimi T, Tomita H, Sato S, et al: Vitamin D receptor gene polymorphism and calcium metabolism in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17 (3): 266-9.
27. Rizzato G, Moutemorro L: The clinical spectrum of sarcoid peripheral lymph node. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17 (1): 71-80.